Australia Cardiovascular Drug Industry Outlook 2022 - 2026

See how Australia Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Sales of beta blocking medicines in Australia are expected to reach $130 million by 2026, growing just 0.8% year-on-year. Since 1995, the Australian market has grown 2.3% each year. In 2021, the country was the fourth biggest in the world, beaten by Canada, which recorded sales of $127 million. Italy, Canada and Australia took the top three spots in the rankings.

Australia Cardiovascular Drug Market Data and Forecasts

Australia Cardiovascular Drug : how will it grow in the coming years?

Forecast: Antihypertensive Medicine Use in Australia
Forecast: Antiarrhythmic Medicine Sales in Australia
Forecast: Diuretic Medicine Sales in Australia
Forecast: Beta Blocking Medicine Sales in Australia
Forecast: Cardiac Glycosides Sales in Australia
Forecast: Diuretic Medicine Sales in Australia

Other Top Countries about Cardiovascular Drug